High risk gestational trophoblastic diseases: Diagnosis and primary management with EMACO chemotherapy

Authors

  • Kadam R. Priyanka Gujarat Cancer Research Institute, Ahmedabad, India
  • Dave S. Pariseema Gujarat Cancer Research Institute, Ahmedabad, India

DOI:

https://doi.org/10.21276/apjhs.2015.2.4.18

Keywords:

Gestational trophoblastic disease, chemotherapy, diagnosis

Abstract

Gestational trophoblastic disease (GTD) is characterized by abnormal proliferation of pregnancy associated trophoblastic tissue with malignant potential. GTD covers a spectrum of tumors and tumor-like conditions and may occur in a benign form as hydatiform mole or as malignancy in the form of invasive mole or choriocarcinoma. Gestational trophoblastic neoplasms are now some of the most curable of all solid tumors, with cure rates >90% even in the presence of widespread metastatic disease. An analytical prospective study of 25 patients with high risk GTN who were evaluated from a period of June 2012 to Nov 2014 at our institute and diagnosis has been described in the paper

Downloads

Download data is not yet available.

Author Biographies

Kadam R. Priyanka, Gujarat Cancer Research Institute, Ahmedabad, India

Department of Gynaecology Oncology, 

Dave S. Pariseema, Gujarat Cancer Research Institute, Ahmedabad, India

Department of Gynaecology Oncology, 

Downloads

Published

2015-12-30

How to Cite

Kadam R. Priyanka, & Dave S. Pariseema. (2015). High risk gestational trophoblastic diseases: Diagnosis and primary management with EMACO chemotherapy. Asian Pacific Journal of Health Sciences, 2(4), 82–86. https://doi.org/10.21276/apjhs.2015.2.4.18